首页> 外文期刊>Hepato-gastroenterology. >Does portal vein resection with hepatectomy improve survival in locally advanced hilar cholangiocarcinoma?
【24h】

Does portal vein resection with hepatectomy improve survival in locally advanced hilar cholangiocarcinoma?

机译:门静脉切除联合肝切除术能否改善局部晚期肝门胆管癌的生存率?

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND/AIMS: Although portal vein resection (PVR) can increase the respectability and curability in locally invading hilar cholangiocarcinoma, there are still controversies in regards to the balance between the risk and the benefit. The present study retrospectively assessed the safety and survival impact of PVR in locally advanced hilar cholangiocarcinoma (HCCA). METHODOLOGY: 259 patients undergoing surgical resection for HCCA between June 1989 and June 2005 were divided into two groups, 51 who underwent PVR (PVR+) and 208 who did not (PVR-). We compared survival and clinicopathological data between these two groups. RESULTS: The 5-yr survival rate of PVR+ group (22.8%) was significantly lower than one of PVR- group (30.9%), but 7 of 51 patients (13.7%) have survived more than 5 yr. Five operative mortalities (9.8%) occurred in PVR+ group, but only 1 of 5 mortalities was directly related to PVR. The morbidity rate and postoperative liver function did not differ between two groups. In the PVR+ group, 28 (54.9%) had actual tumor invasion into the portal vein, but tumor invasion demonstrated no effect on survival. CONCLUSIONS: Although PVR + group demonstrated low survival rate than PVR- group, PVR can offer long-term survival in more than 1 of 10 locally advanced HCCA. However, operative mortality should be lowered to apply PVR in hepatectomy for HCCA.
机译:背景/目的:尽管门静脉切除术(PVR)可以提高局部侵犯肺门胆管癌的可观性和可治愈性,但在风险与收益之间的平衡方面仍存在争议。本研究回顾性评估了PVR在局部晚期肺门胆管癌(HCCA)中的安全性和生存影响。方法:将1989年6月至2005年6月间接受HCCA手术切除的259例患者分为两组,其中51例接受了PVR(PVR +),而208例未进行PVR-)。我们比较了这两组的生存率和临床病理数据。结果:PVR +组的5年生存率(22.8%)明显低于PVR-组的3年生存率(30.9%),但51例患者中有7例(13.7%)的生存期超过5年。 PVR +组有5例手术死亡(9.8%),但5例死亡中只有1例与PVR直接相关。两组的发病率和术后肝功能无差异。在PVR +组中,有28名(54.9%)的肿瘤实际侵入了门静脉,但肿瘤的侵入对生存没有影响。结论:尽管PVR +组的生存率低于PVR-组,但PVR可以在10种局部晚期HCCA中提供1种以上的长期生存。但是,应降低手术死亡率,以便在HCCA肝切除术中应用PVR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号